-
-
-
-
-
-
-
FDA delays reviews of Sanofi's Tzield and Disc Medicine's bitopertin
-
-
-
-
-
-
-
Disc Medicine (IRON) PT Raised to $117 at Raymond James
-
-
-
-
-
-
-
Truist on Disc Medicine (IRON): 'A Bullish Indicator If We Ever Saw One'
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Disc Medicine (IRON)
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Disc Medicine (IRON)
-
-
-
-
-
-
-
TD Cowen Starts Disc Medicine (IRON) at Buy
-
-
-
-
-
-
-
Jefferies Reiterates Buy Rating on Disc Medicine (IRON)
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

